AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
208.36
+5.58 (2.75%)
May 12, 2026, 2:49 PM EDT - Market open
AbbVie Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,641 | 4,233 | 4,286 | 4,873 | 11,845 | 11,549 |
Depreciation & Amortization | 8,036 | 8,139 | 8,386 | 8,698 | 8,467 | 8,521 |
Stock-Based Compensation | 989 | 955 | 911 | 747 | 671 | 692 |
Other Adjustments | 9,415 | 8,065 | 8,005 | 5,708 | 4,054 | 3,246 |
Change in Receivables | 76 | -1,490 | 207 | 66 | -1,455 | -1,321 |
Changes in Inventories | -263 | -234 | -319 | -417 | -686 | -142 |
Changes in Income Taxes Payable | -1,221 | -762 | -3,208 | -488 | 542 | -1,290 |
Changes in Other Operating Activities | -296 | 124 | 538 | 3,652 | 1,505 | 1,522 |
Operating Cash Flow | 21,224 | 19,030 | 18,806 | 22,839 | 24,943 | 22,777 |
Operating Cash Flow Growth | 29.41% | 1.19% | -17.66% | -8.43% | 9.51% | 29.50% |
Capital Expenditures | -1,244 | -1,214 | -974 | -777 | -695 | -787 |
Purchases of Investments | -24 | -35 | -73 | -77 | -1,438 | -119 |
Proceeds from Sale of Investments | 56.5 | 76 | 555 | 55 | 1,530 | 98 |
Payments for Business Acquisitions | -5,169 | -5,441 | -20,517 | -1,223 | -794 | -1,902 |
Other Investing Activities | -88 | -29 | 189 | 13 | 774 | 366 |
Investing Cash Flow | -6,482 | -6,643 | -20,820 | -2,009 | -623 | -2,344 |
Short-Term Debt Issued | 2,795 | 4,798 | 5,008 | - | - | - |
Short-Term Debt Repaid | -4,798 | -2,798 | -5,008 | - | - | - |
Net Short-Term Debt Issued (Repaid) | -2,004 | 2,000 | 0 | - | - | - |
Long-Term Debt Issued | 7,991 | 3,994 | 16,963 | - | 2,000 | 1,000 |
Long-Term Debt Repaid | -3,771 | -6,797 | -9,613 | -4,149 | -14,433 | -9,414 |
Net Long-Term Debt Issued (Repaid) | 4,220 | -2,803 | 7,350 | -4,149 | -12,433 | -8,414 |
Issuance of Common Stock | 141.5 | 172 | 214 | 180 | 262 | 244 |
Repurchase of Common Stock | -1,508 | -980 | -1,708 | -1,972 | -1,487 | -934 |
Net Common Stock Issued (Repurchased) | -1,367 | -808 | -1,494 | -1,792 | -1,225 | -690 |
Common Dividends Paid | -11,818 | -11,657 | -11,025 | -10,539 | -10,043 | -9,261 |
Other Financing Activities | -1,566 | 544 | -42 | -742 | -1,102 | -674 |
Financing Cash Flow | -10,547 | -12,724 | -5,211 | -17,222 | -24,803 | -19,039 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 21 | 42 | -65 | 5 | -62 | -97 |
Net Cash Flow | 4,216 | -295 | -7,290 | 3,613 | -545 | 1,297 |
Free Cash Flow | 19,980 | 17,816 | 17,832 | 22,062 | 24,248 | 21,990 |
Free Cash Flow Growth | 12.15% | -0.09% | -19.17% | -9.01% | 10.27% | 30.97% |
FCF Margin | 31.81% | 29.13% | 31.65% | 40.62% | 41.77% | 39.13% |
Free Cash Flow Per Share | 11.27 | 10.05 | 10.06 | 12.44 | 13.64 | 12.37 |
Levered Free Cash Flow | 10,864 | 9,476 | 16,051 | 11,382 | 8,536 | 10,952 |
Unlevered Free Cash Flow | 14,355 | 15,726 | 14,962 | 20,614 | 25,056 | 23,761 |
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.